Found: 3
Select item for more details and to access through your institution.
MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 3, p. 612, doi. 10.1007/s12094-020-02456-x
- By:
- Publication type:
- Article
Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 11, p. 2017, doi. 10.1007/s12094-020-02341-7
- By:
- Publication type:
- Article
Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 7, p. 1138, doi. 10.1007/s12094-019-02240-6
- By:
- Publication type:
- Article